Page last updated: 2024-10-15

2-keto-4-methylvalerate and Memory Disorders

2-keto-4-methylvalerate has been researched along with Memory Disorders in 1 studies

alpha-ketoisocaproic acid: RN given refers to parent cpd
4-methyl-2-oxopentanoate : A 2-oxo monocarboxylic acid anion that is the conjugate base of 4-methyl-2-oxopentanoic acid.
4-methyl-2-oxopentanoic acid : A 2-oxo monocarboxylic acid that is pentanoic acid (valeric acid) substituted with a keto group at C-2 and a methyl group at C-4. A metabolite that has been found to accumulate in maple syrup urine disease.

Memory Disorders: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taschetto, L1
Scaini, G1
Zapelini, HG1
Ramos, ÂC1
Strapazzon, G1
Andrade, VM1
Réus, GZ1
Michels, M1
Dal-Pizzol, F1
Quevedo, J1
Schuck, PF1
Ferreira, GC1
Streck, EL1

Other Studies

1 other study available for 2-keto-4-methylvalerate and Memory Disorders

ArticleYear
Acute and long-term effects of intracerebroventricular administration of α-ketoisocaproic acid on oxidative stress parameters and cognitive and noncognitive behaviors.
    Metabolic brain disease, 2017, Volume: 32, Issue:5

    Topics: Animals; Avoidance Learning; Behavior, Animal; Catalase; Cognition; Injections, Intraventricular; Ke

2017